Incannex Healthcare Inc.
IXHL
$3.12
-$0.20-5.89%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -86.05% | 616.67% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -86.05% | 616.67% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -86.05% | 616.67% | -- | -- |
| SG&A Expenses | -0.52% | -16.07% | -23.51% | 3.16% | 36.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.97% | -1.43% | 18.80% | 26.25% | 58.40% |
| Operating Income | -15.49% | 1.11% | -18.42% | -25.65% | -57.70% |
| Income Before Tax | -103.98% | -107.03% | -154.41% | -34.26% | -73.40% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -103.73% | -106.76% | -154.00% | -34.45% | -73.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -103.73% | -106.76% | -154.00% | -34.45% | -73.61% |
| EBIT | -15.49% | 1.11% | -18.42% | -25.65% | -57.70% |
| EBITDA | -15.89% | 1.70% | -17.52% | -24.05% | -56.13% |
| EPS Basic | 55.62% | 32.88% | -7.83% | -20.02% | -62.15% |
| Normalized Basic EPS | 59.58% | 36.83% | -3.02% | -14.87% | -61.93% |
| EPS Diluted | 55.62% | 32.88% | -7.83% | -20.02% | -62.15% |
| Normalized Diluted EPS | 59.58% | 36.83% | -3.02% | -14.87% | -61.93% |
| Average Basic Shares Outstanding | 1,018.40% | 548.33% | 113.43% | 13.30% | 7.38% |
| Average Diluted Shares Outstanding | 1,018.40% | 548.33% | 113.43% | 13.30% | 7.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |